Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe

Colaboración

Año: 2018

Colagrossi, L; Hermans, LE; Salpini, R; Di Carlo, D; Pas, SD; Alvarez, M; Ben-Ari, Z; Boland, G; Bruzzone, B; Coppola, N; Seguin-Devaux, C; Dyda, T; Garcia, F; Kaiser, R; Kose, S; Krarup, H; Lazarevic, I; Lunar, MM; Maylin, S; Micheli, V; Mor, O; Paraschiv, S; Paraskevis, D; Poljak, M; Puchhammer-Stockl, E; Simon, F; Stanojevic, M; Stene-Johansen, K; Tihic, N; Trimoulet, P; Verheyen, J; Vince, A; Lepej, SZ; Weis, N; Yalcinkaya, T; Boucher, CAB; Wensing, AMJ; Perno, CF; Svicher, V

Título: BMC INFECTIOUS DISEASES

• Q2